Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Goal Directed Therapy Using a Physiological Holistic View. A Multicenter Study in Latin America: The ANDROMEDA-SHOCK Study

NCT03078712 is registered in ClinicalTrials.gov with Pontificia Universidad Catolica de Chile as lead sponsor.

NCT NCT03078712
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03078712 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Goal Directed Therapy Using a Physiological Holistic View. A Multicenter Study in Latin America: The ANDROMEDA-SHOCK Study
Lead sponsor
Pontificia Universidad Catolica de Chile
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2017
Completion date
June 30, 2018
Enrollment
424 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperlactatemia, peripheral perfusion, septic shock